ライフサイエンスコーパス: esophagogastroduodenoscopy

1 Gut T(H)2 cells were obtained by means of esophagogastroduodenoscopy.

2 derwent 48-hour esophageal pH monitoring and esophagogastroduodenoscopy.

3 in cirrhosis patients to prevent unnecessary esophagogastroduodenoscopy.

4 ered a dyspepsia questionnaire and underwent esophagogastroduodenoscopy.

5 en underwent either serologic testing and/or esophagogastroduodenoscopy.

6 logic findings and 11 had normal findings at esophagogastroduodenoscopy.

7 taken and underwent colonoscopy, followed by esophagogastroduodenoscopy.

8 e 10 patients, esophagitis was documented by esophagogastroduodenoscopy.

9 hageal tumor biopsy samples collected during esophagogastroduodenoscopy.

10 19 years) who underwent clinically indicated esophagogastroduodenoscopy.

11 2 esophagitis) had a pathological finding in esophagogastroduodenoscopy.

12 rmed among patients with cirrhosis; 92% were esophagogastroduodenoscopies.

13 ning TDF (n = 12) or TAF (n = 12), underwent esophagogastroduodenoscopies.

14 Patients were evaluated by esophagogastroduodenoscopy, 24-hour esophageal pH studie

15 tive evaluation included symptom assessment, esophagogastroduodenoscopy, 24-hour pH evaluation, and e

16 efinition) on PPIs underwent barium swallow, esophagogastroduodenoscopy, 48-hour esophageal pH monito

17 ve unexplained nausea but normal findings on esophagogastroduodenoscopy, a gastric-emptying test, and

18 ded diagnostic accuracy of 94.0% relative to esophagogastroduodenoscopy and 76.8% relative to bone ma

19 They underwent esophagogastroduodenoscopy and biopsies were collected a

20 Esophagogastroduodenoscopy and colonoscopy did not revea

21 ntestinal bleeding, and negative findings on esophagogastroduodenoscopy and colonoscopy, CE should be

22 sponsive to nutrition intervention underwent esophagogastroduodenoscopy and duodenal biopsies.

23 o have CD-associated antibodies were offered esophagogastroduodenoscopy and duodenal biopsy analysis.

24 ong eligible patients scheduled for elective esophagogastroduodenoscopy and patients eligible for scr

25 s; n = 21), or non-GERD (normal results from esophagogastroduodenoscopy and pH tests; n = 24).

26 We enrolled patients scheduled for esophagogastroduodenoscopy and positive for H. pylori in

27 ined a cohort (0-21 yrs.) who have undergone esophagogastroduodenoscopy and received disaccharidase a

28 Post-procedure esophagogastroduodenoscopy and repeat cardiac computed t

29 pants then were selected randomly to undergo esophagogastroduodenoscopy and were given the Abdominal

30 2,091,590 veterans who underwent outpatient esophagogastroduodenoscopy and/or colonoscopy during fis

31 e study of veterans who underwent outpatient esophagogastroduodenoscopy and/or colonoscopy from fisca

32 sults from guideline-compatible work-up (CT, esophagogastroduodenoscopy, and bone marrow-derived biop

33 ients were also assessed by FibroScan, HVPG, esophagogastroduodenoscopy, and liver biopsy.

34 ombined hepatic and cardiac catheterization, esophagogastroduodenoscopy, and liver biopsy.

35 luded eosinophils per high power field (from esophagogastroduodenoscopy biopsy: proximal, distal), en

36 ardia and duodenal bulb was performed during esophagogastroduodenoscopy, but histologic findings at h

37 underwent a diagnostic workup that included esophagogastroduodenoscopy, colonoscopy, and barium radi

38 Esophagogastroduodenoscopy, colonoscopy, and pathology r

39 rminate source and had negative results from esophagogastroduodenoscopy, colonoscopy, small-bowel exa

40 The esophagogastroduodenoscopy confirmed the ischemic change

41 resence and grade of varices at pretreatment esophagogastroduodenoscopy did not correlate with bleedi

42 in tissue biopsy from endoscopy in 1 from 10 esophagogastroduodenoscopies (EGD), 0 from 7 colonoscopi

43 r gastrointestinal tract observed in 1-3% of esophagogastroduodenoscopies (EGD).

44 it has been suggested that VCE could replace esophagogastroduodenoscopy (EGD) and biopsy under certai

45 In adults, esophagogastroduodenoscopy (EGD) and duodenal biopsies m

46 s younger than age 45 with IDA who underwent esophagogastroduodenoscopy (EGD) and/or colonoscopy at t

47 nt portions of the cost and complications of esophagogastroduodenoscopy (EGD) are related to sedation

48 novel liquid-biopsy approach integrated with esophagogastroduodenoscopy (EGD) by analyzing gastric fl

49 namics, time from bleeding, comorbidity, and esophagogastroduodenoscopy (EGD) findings to predict ris

50 Demographics, findings at index esophagogastroduodenoscopy (EGD) first showing GIM, reco

51 ere obtained from patients with dyspepsia on esophagogastroduodenoscopy (EGD) for rapid urease test,

52 ted tomography (CT) in 40 of 53 patients, on esophagogastroduodenoscopy (EGD) in 11 of 36 patients, a

53 Current guidelines recommend esophagogastroduodenoscopy (EGD) in patients with cirrho

54 y, and to determine the role of preresection esophagogastroduodenoscopy (EGD) in predicting the patie

55 Esophagogastroduodenoscopy (EGD) is an effective techniq

56 Esophagogastroduodenoscopy (EGD) is done often for vario

57 Screening esophagogastroduodenoscopy (EGD) is recommended for all

58 79 years, presenting either for their first esophagogastroduodenoscopy (EGD) or their first endoscop

59 nt a major cause of morbidity worldwide, and esophagogastroduodenoscopy (EGD) remains the gold standa

60 practice sites in 21 states provided 18,444 esophagogastroduodenoscopy (EGD) reports, 20,748 colonos

61 unt, have been proposed to avoid unnecessary esophagogastroduodenoscopy (EGD) screening for esophagea

62 Unsedated esophagogastroduodenoscopy (EGD) using conventional 8-11

63 An esophagogastroduodenoscopy (EGD) was performed before an

64 After PV isolation, esophagogastroduodenoscopy (EGD) was performed to assess

65 astrointestinal cancer will have received an esophagogastroduodenoscopy (EGD) within 3 years before d

66 me Helicobacter pylori (HP) diagnosis during esophagogastroduodenoscopy (EGD), based on ammonium leve

67 98 of 575 (51.8%) patients who had undergone esophagogastroduodenoscopy (EGD), colonoscopy or both fo

68 l records of consecutive patients undergoing esophagogastroduodenoscopy (EGD), colonoscopy, and small

69 ncluding clinical evaluation, and results of esophagogastroduodenoscopy (EGD), manometry, and pH moni

70 When undergoing esophagogastroduodenoscopy (EGD), patients with a diagno

71 63 were enrolled in the study; 75% underwent esophagogastroduodenoscopy (EGD), while 25% underwent a

72 oup 1 were found to have NDBE at their first esophagogastroduodenoscopy (EGD).

73 t of the study, 50 adults with EoE underwent esophagogastroduodenoscopies (EGDs), biopsies, and skin-

74 Outcomes of esophagogastroduodenoscopy examinations, histopathology

75 Colonoscopy and esophagogastroduodenoscopy findings were negative for ul

76 clinical presentation, the accompanying EGD [esophagogastroduodenoscopy] findings and other relevant

77 by a urea breath test and were subjected to esophagogastroduodenoscopy, followed by histology, cultu

78 We performed esophagogastroduodenoscopy for AV visualization in 102 >

79 Varices were documented by esophagogastroduodenoscopy in 287 (72.5%) of 396 analyze

80 Esophagogastroduodenoscopy is a key procedure because of

81 sophagus cases by age, race, and gender with esophagogastroduodenoscopy negative for Barrett's esopha

82 ients required mask ventilation during their esophagogastroduodenoscopy or colonoscopy, respectively

83 These participants underwent esophagogastroduodenoscopy procedures with gastric biops

84 Postpyloric administration of SARS-CoV-2 by esophagogastroduodenoscopy resulted in limited virus rep

85 Esophagogastroduodenoscopy revealed asymptomatic esophag

86 Esophagogastroduodenoscopy revealed extensive esophageal

87 Postprocedure esophagogastroduodenoscopy revealed minor mucosal therma

88 We performed esophagogastroduodenoscopy that revealed Los Angeles Gra

89 She was diagnosed by esophagram and esophagogastroduodenoscopy to have esophageal intramural

90 Median time from first esophagogastroduodenoscopy to stage 4 disease was 22.4 y

91 ing (VB) episodes, in whom unnecessary upper esophagogastroduodenoscopy (UGE) screening can be safely

92 Esophagogastroduodenoscopy was performed after 4 wk to a

93 Esophagogastroduodenoscopy was performed because of a su

94 Esophagogastroduodenoscopy was performed before and afte

95 An esophagogastroduodenoscopy was performed in the AH and A

96 372 consecutive patients undergoing esophagogastroduodenoscopy were carefully searched for t

97 Barium swallows and esophagogastroduodenoscopy were performed in all patient

98 Multiple esophagogastroduodenoscopies with normal gastric and duo

99 ported outcome instrument and then underwent esophagogastroduodenoscopy with esophageal biopsy collec

100 d tissue (MALT) lymphoma currently relies on esophagogastroduodenoscopy with histological assessment

101 h HVPG below 12 mmHg and prevent unnecessary esophagogastroduodenoscopy with its associated morbidity

102 prospective study of 69 patients undergoing esophagogastroduodenoscopy with or without wireless pH m

103 ional study in adult EoE patients undergoing esophagogastroduodenoscopy with propofol sedation was co

104 Esophagogastroduodenoscopy with small bowel biopsies sho

105 ss-sectional study of patients who underwent esophagogastroduodenoscopy with submission of gastric an